Vicks Vapodrops

Description

VICKS® VapoDrops™ are formulated with menthol, serving as a cough suppressant and oral anesthetic. These medicated drops provide effective cough relief and are presented in a cherry flavor. Each package contains 50 medicated drops, designed for convenient use.

Uses and Indications

This drug is indicated for the temporary relief of cough associated with a cold. Additionally, it provides temporary relief from occasional minor irritation or sore throat.

There are no teratogenic effects associated with this drug, and no nonteratogenic effects have been reported.

Dosage and Administration

Adults and children aged 12 years and older are instructed to dissolve 1 drop slowly in the mouth. This process may be repeated every 2 hours as needed or as directed by a healthcare professional.

The use of this medication is not recommended for children under 12 years of age.

Contraindications

There are no specified contraindications for the use of this product. It is important to evaluate each patient's individual circumstances and medical history to ensure safe and appropriate use.

Warnings and Precautions

Severe or persistent sore throat, particularly when accompanied by high fever, headache, nausea, and vomiting, may indicate a serious condition. Healthcare professionals should advise patients to consult a doctor promptly in such cases. It is important to note that the product should not be used for more than 2 days or administered to children under 12 years of age unless specifically directed by a physician.

Before recommending this product, healthcare providers should inquire about the patient's medical history. Patients with a persistent or chronic cough, such as that associated with smoking, asthma, or emphysema, should seek medical advice prior to use. Additionally, caution is warranted for those experiencing a cough accompanied by excessive phlegm (mucus) or a severe sore throat that is associated with difficulty in breathing or lasts longer than 2 days.

Patients should be instructed to discontinue use and contact their healthcare provider if the cough persists for more than 1 week, recurs, or is accompanied by fever, rash, or a persistent headache. Furthermore, if symptoms of a sore mouth do not improve within 7 days, or if irritation, pain, or redness persists or worsens, medical consultation is advised.

In the event of an overdose, immediate medical assistance should be sought, or the patient should contact a Poison Control Center without delay.

Side Effects

Patients may experience a range of adverse reactions associated with the use of this medication.

Severe or persistent sore throat, particularly when accompanied by high fever, headache, nausea, and vomiting, may indicate a serious condition. Patients are advised to consult a healthcare professional promptly in such cases. It is important to note that the medication should not be used for more than 2 days or administered to children under 12 years of age unless directed by a doctor.

Before using this medication, patients should seek medical advice if they have a persistent or chronic cough, such as that associated with smoking, asthma, or emphysema. Additionally, a cough accompanied by excessive phlegm (mucus) or a severe sore throat that causes difficulty in breathing or lasts more than 2 days warrants consultation with a healthcare provider.

Patients should discontinue use and consult a doctor if the cough persists for more than 1 week, tends to recur, or is accompanied by fever, rash, or a persistent headache. Furthermore, if symptoms of a sore mouth do not improve within 7 days, or if irritation, pain, or redness persists or worsens, medical advice should be sought.

In the event of an overdose, patients are urged to seek medical help or contact a Poison Control Center immediately.

Drug Interactions

No specific drug interactions have been identified in the available data. Additionally, there are no reported interactions between the drug and laboratory tests. Therefore, no dosage adjustments or monitoring recommendations are necessary based on the current information.

Packaging & NDC

Below are the non-prescription pack sizes of Vicks Vapodrops (menthol). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 12 years of age should not use this medication unless directed by a healthcare professional. For patients aged 12 years and older, the recommended dosage is to dissolve 1 drop slowly in the mouth, with the option to repeat every 2 hours as needed or as directed by a physician. Caution is advised when considering use in younger populations, and healthcare providers should evaluate the necessity of treatment on a case-by-case basis.

Geriatric Use

There is no specific information regarding the use of VICKS VapoDrops in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when administering this product to elderly patients, as they may have altered pharmacokinetics or comorbidities that could affect the drug's efficacy and safety profile. Monitoring for potential adverse effects is advisable in this population, given the lack of targeted clinical findings or recommendations for geriatric use.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. The potential risks and benefits must be carefully considered, as the effects on fetal outcomes and lactation are not fully established. It is essential for women of childbearing potential to discuss their individual circumstances with a healthcare provider to ensure safe use during pregnancy and lactation.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no available data on the excretion of this medication in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Patients with renal impairment have no specific information regarding dosage adjustments, special monitoring, or safety considerations provided in the drug insert. Therefore, healthcare professionals should exercise caution when prescribing this medication to individuals with reduced kidney function, as the lack of data necessitates careful clinical judgment.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to this drug. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the prescribing information.

Overdosage

In the event of an overdose, it is imperative to seek immediate medical assistance or contact a Poison Control Center without delay. Prompt intervention is crucial to mitigate potential adverse effects associated with the overdose.

Healthcare professionals should be aware that the specific symptoms of an overdose may vary depending on the substance involved. Therefore, a thorough assessment of the patient's condition is essential to determine the appropriate course of action.

Management of an overdose typically involves supportive care and symptomatic treatment. Continuous monitoring of the patient's vital signs and clinical status is recommended. In cases where the specific substance is known, targeted therapies may be employed as indicated.

It is essential for healthcare providers to remain vigilant and act swiftly in the event of an overdose to ensure optimal patient outcomes.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in question.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children to prevent accidental ingestion. Patients should be instructed to stop using the medication and consult a doctor if their cough persists for more than one week, tends to recur, or is accompanied by fever, rash, or a persistent headache. Additionally, if symptoms of a sore mouth do not improve within 7 days, or if irritation, pain, or redness persists or worsens, patients should seek medical advice.

It is important for healthcare providers to encourage patients to ask a doctor before using the medication if they have a persistent or chronic cough, such as that which occurs with smoking, asthma, or emphysema. Patients should also be advised to consult a doctor if their cough is accompanied by excessive phlegm (mucus) or if they experience a severe sore throat that is accompanied by difficulty in breathing or lasts more than 2 days.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product at a temperature not exceeding 25°C (77°F) to maintain its integrity and efficacy. Proper storage conditions should be ensured to prevent any degradation of the product.

Additional Clinical Information

The medication is administered orally. For adults and children aged 12 years and older, the recommended dosage is to dissolve 1 drop slowly in the mouth, with the option to repeat every 2 hours as needed or as directed by a healthcare professional. It is contraindicated for use in children under 12 years of age. No additional information is available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Vicks Vapodrops, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)